Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
NCT ID: NCT00176202
Description: None
Frequency Threshold: 5
Time Frame: Weekly from baseline and for 6 weeks; 7 waves of data.
Study: NCT00176202
Study Brief: Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Risperidone Likely side effects include weight gain, muscle stiffness, sedation and tiredness. Clarification: We did not note any serious side effects with either drug. We reported any adverse event that is found in greater than 5% of the participants in each group. Frequency of adverse events do not equal the fact that they are serious adverse events at any individual level. None None 0 32 8 32 View
Depakote or Divalproex Sodium Likely side effects include gastrointestinal side effects such as stomach discomfort, weight gain, agitation and sedation, fatigue or tiredness. Clarification: We did not note any serious side effects with either drug. We reported any adverse event that is found in greater than 5% of the participants in each group. Frequency of adverse events do not equal the fact that they are serious adverse events at any individual level. None None 0 33 10 33 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
sleepiness SYSTEMATIC_ASSESSMENT Nervous system disorders None View
fatigue/tiredness SYSTEMATIC_ASSESSMENT Nervous system disorders None View
insomnia SYSTEMATIC_ASSESSMENT Nervous system disorders None View
weight gain SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Increased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Irritable/agitated SYSTEMATIC_ASSESSMENT Nervous system disorders None View
stomach discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View